Company Filing History:
Years Active: 2018-2021
Title: Coleman Gross: Innovator in Cushing's Syndrome Treatment
Introduction
Coleman Gross is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of medicine, particularly in the treatment of Cushing's syndrome. With a total of five patents to his name, Gross has demonstrated a commitment to advancing healthcare solutions.
Latest Patents
One of his latest patents focuses on optimizing mifepristone levels for patients suffering from Cushing's syndrome. The invention provides a method that includes treating the patient with seven or more daily doses of mifepristone over a period of seven or more days. It also involves testing the serum levels of the patient to determine whether the blood levels of mifepristone exceed 1631 ng/mL. If necessary, the daily dose is adjusted to achieve the desired mifepristone blood levels.
Career Highlights
Coleman Gross is currently associated with Corcept Therapeutics Incorporated, where he continues to work on innovative solutions for patients. His expertise and dedication have positioned him as a key figure in the development of effective treatments for complex medical conditions.
Collaborations
His work often involves collaboration with other professionals in the field, including his coworker Joseph K Belanoff. Together, they strive to enhance patient care through innovative research and development.
Conclusion
Coleman Gross is a prominent inventor whose work in optimizing treatments for Cushing's syndrome has the potential to significantly improve patient outcomes. His contributions to the medical field exemplify the importance of innovation in healthcare.